Article

Clinical assessment of liraglutide use in prediabetic and obese schizophrenic patients: A systematic literature review and meta-analysis

2023-08-02

Abstract excerpt

<h4>Background: </h4> and Hypothesis Schizophrenic patients are at a higher risk of developing prediabetes and obesity, which may increase their risk of cardiovascular and other diseases. Liraglutide, a glucagon-like peptide-1 receptor agonist, is effective in treating prediabetes and obesity in the general population. However, its efficacy and safety in schizophrenic patients remain unclear. This study aims to ev...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 13938f6d-f14b-5ce1-ad3a-317e8e489df9
DOI: 10.21203/rs.3.rs-3150409/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Clinical assessment of liraglutide use in prediabetic and obese schizophrenic patients: A systematic literature review and meta-analysisDOI 10.21203/rs.3.rs-3150409/v1Read

Exploring the off-Label use of liraglutide in the treatment of obesity: a reviewSemantic proximity Read

Liraglutide and the Management of Overweight and Obesity in People with Severe Mental Illness: Qualitative Sub-StudySemantic proximity Read

Impact of Glucagon-like Peptide-1 Receptor Agonists on Mental Illness: Evidence from a Mendelian Randomization StudySemantic proximity Read

Drawbacks of Olanzapine Therapy: An Emphasis on Its Metabolic Effects and DiscontinuationSemantic proximity Read

Waist-Height ratio Highlights Detrimental Risk for Olanzapine Associated Weight Gain Earlier than Body Mass Index.Semantic proximity Read

Liraglutide Use in A Real-World Setting: Patient Characteristics at Antidiabetic Treatment Initiation Modulate Cardiovascular Safety OutcomesSemantic proximity Read

Anti-stress effects of the glucagon-like peptide-1 receptor agonist liraglutide in zebrafishSemantic proximity Read

Highway to the danger zone? A cautionary account that GLP-1 receptor agonists may be too effective for unmonitored weight lossSemantic proximity Read

Tirzepatide for LipodystrophySemantic proximity Read

Polymorphisms of INSIG2, MC4R, and LEP Are Associated With Obesity- and Metabolic-Related Traits in Schizophrenic PatientsSemantic proximity Read

Gender differences in prevalence and associated factors of metabolic syndrome in first-treatment and drug-naïve schizophrenia patientsSemantic proximity Read

Obesity and metabolic comorbidity in bipolar disorder: Do patients on lithium comprise a subgroup? A naturalistic study.Semantic proximity Read